Mainz Biomed Bv Stock Last Dividend Paid
| MYNZ Stock | USD 0.20 0.02 9.09% |
Mainz Biomed BV fundamentals help investors to digest information that contributes to Mainz Biomed's financial success or failures. It also enables traders to predict the movement of Mainz Stock. The fundamental analysis module provides a way to measure Mainz Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mainz Biomed stock.
Mainz | Last Dividend Paid |
Mainz Biomed BV Company Last Dividend Paid Analysis
Mainz Biomed's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Mainz Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Mainz Biomed is extremely important. It helps to project a fair market value of Mainz Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Mainz Biomed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mainz Biomed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mainz Biomed's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Mainz Dividend Paid And Capex Coverage Ratio
Dividend Paid And Capex Coverage Ratio |
|
Based on the recorded statements, Mainz Biomed BV has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Mainz Fundamentals
| Return On Equity | -43.34 | ||||
| Return On Asset | -0.99 | ||||
| Operating Margin | (18.83) % | ||||
| Current Valuation | 21.38 M | ||||
| Shares Outstanding | 64.04 M | ||||
| Shares Owned By Insiders | 5.52 % | ||||
| Shares Owned By Institutions | 0.24 % | ||||
| Number Of Shares Shorted | 3.57 M | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 17.87 X | ||||
| Revenue | 895.48 K | ||||
| Gross Profit | 177.62 K | ||||
| EBITDA | (25.01 M) | ||||
| Net Income | (26.3 M) | ||||
| Cash And Equivalents | 26.01 M | ||||
| Cash Per Share | 1.80 X | ||||
| Total Debt | 7.42 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 10.83 X | ||||
| Book Value Per Share | (0.16) X | ||||
| Cash Flow From Operations | (21.94 M) | ||||
| Short Ratio | 0.76 X | ||||
| Earnings Per Share | (1.11) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 65 | ||||
| Beta | 0.076 | ||||
| Market Capitalization | 16.39 M | ||||
| Total Asset | 15.41 M | ||||
| Retained Earnings | (69.33 M) | ||||
| Working Capital | (257.15 K) | ||||
| Net Asset | 15.41 M |
About Mainz Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mainz Biomed BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mainz Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mainz Biomed BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.